Regulatory Updates
Sep 3, 2026•1 min read
FDA Approves ANDA078511 for Midazolam Hydrochloride Injection
FDA approved ANDA078511 submitted by PH HEALTH for two injectable Midazolam Hydrochloride products (1 mg/mL and 5 mg/mL), both listed as discontinued.
Regulatory Updates
Sep 2, 2026•1 min read
South Korea Tightens Penalties for Drug‑Impaired Driving After Apgujeong Rolls‑Royce Incident
The August 2023 Apgujeong Rolls‑Royce crash, involving a driver under the influence of seven prescription psychoactive drugs, spurred stricter penalties for drug‑impaired driving under Korea’s revised road traffic law.